Your browser doesn't support javascript.
loading
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial.
Yim, Kendrick; Ma, Chaoran; Carlsson, Sigrid; Lilja, Hans; Mucci, Lorelei; Penney, Kathryn; Kibel, Adam S; Eggener, Scott; Preston, Mark A.
  • Yim K; Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ma C; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Carlsson S; Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lilja H; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • Mucci L; Department of Pathology and Laboratory Medicine, Surgery, and Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Penney K; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Kibel AS; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Eggener S; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Preston MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
J Urol ; 210(4): 630-638, 2023 10.
Article en En | MEDLINE | ID: mdl-37384841

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article